Skip to main content
Log in

Emotional disclosure interventions for chronic pain: from the laboratory to the clinic

  • Published:
Translational Behavioral Medicine

ABSTRACT

Life stress and the avoidance of negative emotions may contribute to chronic pain. The technique of written or spoken emotional disclosure can reverse emotional avoidance and improve health, and 18 randomized studies have tested it among people with chronic pain. We review these studies to provide guidance for the clinical use of this technique. The benefits of emotional disclosure for chronic pain are quite modest overall. Studies in rheumatoid arthritis show very limited effects, but two studies in fibromyalgia suggest that disclosure may be beneficial. Effects in other populations (headaches, cancer pain, pelvic pain, abdominal pain) are mixed. Moderator findings suggest that some patients are more likely to benefit than others. Emotional disclosure has been tested in well-controlled efficacy trials, leaving many unanswered questions related to translating this technique to practice. Issues needing further study include determining disclosure’s effects outside of randomized controlled trials, identifying the optimal pain populations and specific individuals to target for disclosure, presenting a valid rationale for disclosure, selecting the location and method of disclosure, and choosing between cognitive–behavioral or emotional disclosure techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lumley M, Cohen J, Borszcz G, et al. Pain and emotion: a biopsychosocial review of recent research. J Clin Psychol. 2011; 67:1-27.

    Article  Google Scholar 

  2. Davis DA, Luecken LJ, Zautra AJ. Are reports of childhood abuse related to the experience of chronic pain in adulthood? A meta-analytic review of the literature. Clin J Pain. 2005; 21(5):398-405.

    Article  PubMed  Google Scholar 

  3. Imbierowicz K, Egle UT. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur J Pain. 2003; 7:113-119.

    Article  PubMed  Google Scholar 

  4. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006; 332:749-755.

    Article  PubMed  Google Scholar 

  5. Sumanen M, Rantala A, Sillanmäki LH, Mattila KJ. Childhood adversities experienced by working-age migraine patients. J Psychosom Res. 2007; 62:139-143.

    Article  PubMed  Google Scholar 

  6. Davis MC, Zautra AJ, Reich JW. Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis. Ann Behav Med. 2001; 23:215-226.

    Article  PubMed  CAS  Google Scholar 

  7. Eisenberger NI, Jarcho JM, Lieberman MD, Naliboff BD. An experimental study of shared sensitivity to physical pain and social rejection. Pain. 2006; 126:132-138.

    Article  PubMed  Google Scholar 

  8. Kivimaki M, Leino-Arjas P, Virtanen M, et al. Work stress and incidence of newly diagnosed fibromyalgia prospective cohort study. J Psychosom Res. 2004; 57:417-422.

    PubMed  Google Scholar 

  9. Rhudy JL, Williams AE, McCabe KM, Russell JL, Maynard LJ. Emotional control of nociceptive reactions (ECON): do affective valence and arousal play a role? Pain. 2008; 136:250-261.

    Article  PubMed  Google Scholar 

  10. Lumley MA. The two views of emotion in psychosomatic research. J Psychosom Res. 2010; 68:219-221.

    Article  PubMed  Google Scholar 

  11. Davis MC, Zautra AJ, Smith BW. Chronic pain, stress, and the dynamics of affective differentiation. J Personal. 2004; 72:1133-1160.

    Article  Google Scholar 

  12. Hayes SC, Wilson KG, Gifford EV, Follette VM, Strosahl K. Experimental avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. J Consult Clin Psychol. 1996; 64:1152-1168.

    Article  PubMed  CAS  Google Scholar 

  13. Lane RD, Waldstein SR, Critchley HD, et al. The rebirth of neuroscience in psychosomatic medicine, part II: clinical applications and implications for research. Psychosom Med. 2009; 71:135-151.

    Article  PubMed  Google Scholar 

  14. van Houdenhove B, Egle U, Luyten P. The role of life stress in fibromyalgia. Curr Rheumatol Rep. 2005; 7:365-370.

    Article  PubMed  Google Scholar 

  15. Carson JW, Keefe FJ, Lowrey KP, Porter LS, Goli V, Fras AM. Conflict about expressing emotions and chronic low back pain: associations with pain and anger. J Pain. 2007; 8:405-411.

    Article  PubMed  Google Scholar 

  16. Porter LS, Keefe FJ, Lipkus I, Hurwitz H. Ambivalence over emotional expression in patients with gastrointestinal cancer and their caregivers: associations with patient pain and quality of life. Pain. 2005; 117:340-348.

    Article  PubMed  Google Scholar 

  17. van Middendorp H, Lumley MA, Jacobs JWG, van Doornen LJP, Bijlsma JWJ, Geenen R. Emotions and emotional approach and avoidance strategies in fibromyalgia. J Psychosom Res. 2008; 64:159-167.

    Article  PubMed  Google Scholar 

  18. Wenzlaff RM. Wegner DM thought suppression. Annu Rev Psychol. 2000; 51:59-91.

    Article  PubMed  CAS  Google Scholar 

  19. Gross JJ. Emotion regulation: affective, cognitive, and social consequences. Psychophysiology. 2002; 39:281-291.

    Article  PubMed  Google Scholar 

  20. Burns JW, Quartana PJ, Bruehl S. Anger inhibition and pain: conceptualizations, evidence and new directions. J Behav Med. 2008; 31:259-279.

    Article  PubMed  Google Scholar 

  21. Burns JW, Quartana P, Gilliam W, et al. Effects of anger suppression on pain severity and pain behaviors among chronic pain patients: evaluation of an ironic process model. Heal Psychol. 2008; 27:645-652.

    Article  Google Scholar 

  22. Kearns R, Selligner J, Goodin B. Psychological treatment of chronic pain. Annu Rev Clin Psychol. 2011; 7:411-434.

    Article  Google Scholar 

  23. Barlow D, Lehman C. Advances in the psychosocial treatment of anxiety disorders. Implications for national health care. Arch Gen Psychiatry. 1996; 53:727-735.

    Article  PubMed  CAS  Google Scholar 

  24. Foa E, Kozak M. Emotional processing of fear: exposure to corrective information. Psychol Bull. 1986; 99:20-35.

    Article  PubMed  CAS  Google Scholar 

  25. Pennebaker JW, Barger SD, Tiebout J. Disclosure of traumas and health among holocaust survivors. Psychosom Med. 1989; 51:577-589.

    PubMed  CAS  Google Scholar 

  26. Pennebaker JW, O'Heeron RC. Confiding in others and illness rate among spouses of suicide and accidental-death victims. J Abnorm Psychol. 1984; 93:473-476.

    Article  PubMed  CAS  Google Scholar 

  27. Pennebaker J, Beall S. Confronting a traumatic event: toward an understanding of inhibition and disease. J Abnorm Psychol. 1986; 95:274-281.

    Article  PubMed  CAS  Google Scholar 

  28. Smyth JM. Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol. 1998; 66:174-184.

    Article  PubMed  CAS  Google Scholar 

  29. Smyth J, Stone A, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis, a randomized trial. JAMA. 1999; 281:1304-1309.

    Article  PubMed  CAS  Google Scholar 

  30. Stone AA, Smyth JM, Kaell A, Hurewitz A. Structured writing about stressful events: exploring potential psychological mediators of positive health effects. Heal Psychol. 2000; 19:619-624.

    Article  CAS  Google Scholar 

  31. Broderick J, Stone A, Smyth J, Kaell A. The feasibility and effectiveness of an expressive writing intervention for rheumatoid arthritis via home-based videotaped instructions. Ann Behav Med. 2004; 27:50-59.

    Article  PubMed  Google Scholar 

  32. Kelley JE, Lumley MA, Leisen JCC. Health effects of emotional disclosure in rheumatoid arthritis patients. Heal Psychol. 1997; 16:331-340.

    Article  CAS  Google Scholar 

  33. Lumley M, Leisen J, Partridge R, et al. Does emotional disclosure about stress improve health in rheumatoid arthritis? Randomized, controlled trials of written and spoken disclosure. Pain. 2011; 152:866-877.

    Article  PubMed  Google Scholar 

  34. Wetherell M, Byrne-Davis L, Dieppe P, et al. Effects of emotional disclosure on psychological and physiological outcomes in patients with rheumatoid arthritis: an exploratory home-based study. J Heal Psychol. 2005; 10:277-285.

    Article  Google Scholar 

  35. van Middendorp H, Geenen R, Sorbi MJ, Van Doornen LJP, Bijlsma JWJ. Health and physiological effects of an emotional disclosure intervention adapted for application at home: a randomized clinical trial in rheumatoid arthritis. Psychother Psychosom. 2009; 78:145-151.

    Article  PubMed  Google Scholar 

  36. van Middendorp H, Geenen R. Poor cognitive-emotional processing may impeded the outcome of emotional disclosure interventions. Br J Heal Psychol. 2008; 13:49-52.

    Article  Google Scholar 

  37. Danoff-Burg S, Agee J, Romanoff N, Kremer J, Stronsberg J. Benefit finding and expressive writing in adults with lupus or rheumatoid arthritis. Psychol Heal. 2006; 21:651-665.

    Article  Google Scholar 

  38. Keefe F, Anderson T, Lumley M, et al. A randomized, controlled trial of emotional disclosure in rheumatoid arthritis: can clinician assistance enhance the effects? Pain. 2008; 137:164-172.

    Article  PubMed  Google Scholar 

  39. Gillis M, Lumley M, Mosley-Williams A, Leisen J, Roehrs T. The health effects of at-home written emotional disclosure in fibromyalgia: a randomized trial. Ann Behav Med. 2006; 32:135-146.

    Article  PubMed  Google Scholar 

  40. Broderick JE, Junghaenel DU, Schwartz JE. Written emotional expression produces health benefits in fibromyalgia patients. Psychosom Med. 2005; 67:326-334.

    Article  PubMed  Google Scholar 

  41. Junghaenel D, Schwartz J, Broderick J. Differential efficacy of written emotional disclosure for subgroups of fibromyalgia patients. Br J Heal Psychol. 2009; 13:57-60.

    Article  Google Scholar 

  42. Wallander JL, Madan-Swain A, Klapow J, Saeed S. A randomised controlled trial of written self-disclosure for functional recurrent abdominal pain in youth. Psychol Heal. 2011; 26:433-447.

    Article  Google Scholar 

  43. D'Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Ann Behav Med. 2008; 36:21-32.

    Article  PubMed  Google Scholar 

  44. Kraft CA, Lumley MA, D'Souza PJ, Dooley JA. Emotional approach coping and self-efficacy moderate the effects of written emotional disclosure and relaxation training for people with migraine headaches. Br J Heal Psychol. 2008; 13:67-71.

    Article  Google Scholar 

  45. Graham J, Lobel M, Glass P, Lokshina I. Effects of written anger expression in chronic pain patients: making meaning from pain. J Behav Med. 2008; 31:201-212.

    Article  PubMed  Google Scholar 

  46. Norman SA, Lumley MA, Dooley JA, Diamond MP. For whom does it work? Moderators of the effects of written emotional disclosure in a randomized trial among women with chronic pelvic pain. Psychosom Med. 2004; 66:174-183.

    Article  PubMed  Google Scholar 

  47. Cepeda MS, Chapman R, Miranda N, et al. Emotional disclosure through patient narrative may improve pain and well-being: results of a randomized controlled trial in patients with cancer pain. J Pain Symptom Manag. 2008; 35:623-631.

    Article  Google Scholar 

  48. Freyd JJ, Klest B, Allard CB. Betrayal trauma: relationship to physical health, psychological distress, and a written disclosure intervention. J Trauma Dissociation. 2005; 6:83-104.

    Article  PubMed  Google Scholar 

  49. Frisina PG, Borod JC, Lepore S. A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. J Nerv Ment Dis. 2004; 192:629-634.

    Article  PubMed  Google Scholar 

  50. Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychol Bull. 2006; 132:823-865.

    Article  PubMed  Google Scholar 

  51. Harris AH. Does expressive writing reduce health care utilization? A meta-analysis of randomized trials. J Consult Clin Psychol. 2006; 74:243-252.

    Article  PubMed  Google Scholar 

  52. Lumley M, Tojek T, Macklem D. The effects of written emotional disclosure among repressive and alexithymic people. In: Lepore SJ, Smyth JM, eds. The writing cure: how expressive writing promotes health and emotional well-being. Washington, DC: American Psychological Association; 2002:75-95.

    Chapter  Google Scholar 

  53. Solano L, Donati V, Pecci F, Persichetti S, Colaci A. Postoperative course after papilloma resection: effects of written disclosure of the experience in subjects with different alexithymia levels. Psychosom Med. 2003; 65:477-484.

    Article  PubMed  Google Scholar 

  54. Zakowski SG, Ramati A, Morton C, Johnson P, Flanigan R. Written emotional disclosure buffers the effects of social constraints on distress among cancer patients. Heal Psychol. 2004; 23:555-563.

    Article  Google Scholar 

  55. Walker E, Keegan D, Gardner G, et al. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: II. Sexual, physical, and emotional abuse and neglect. Psychosom Med. 1997; 59:572-577.

    PubMed  CAS  Google Scholar 

  56. Brosschot JF, Aarsse HR. Restricted emotional processing and somatic attribution in fibromyalgia. Int J Psychiatr Med. 2001; 31:127-146.

    Article  CAS  Google Scholar 

  57. Byrne-Davis L, Wetherell M, Dieppe P, et al. Emotional disclosure in rheumatoid arthritis: participants’ views on mechanisms. Psychol Heal. 2006; 21:667-682.

    Article  Google Scholar 

  58. Smyth JM, Catley D. Translating research into practice: potential of expressive writing in the field. In: Lepore SJ, Smyth JM, eds. The writing cure: how expressive writing promotes health and emotional well-being. Washington, DC: American Psychological Association; 2002:199-214.

    Chapter  Google Scholar 

  59. Nazarian D, Smyth JM. Context moderates the effects of an expressive writing intervention: a randomized two-study replication and extension. J Soc Clin Psychol. 2010; 29:903-929.

    Article  Google Scholar 

  60. Radcliffe A, Lumley M, Kendall J, Stevenson J, Beltran J. Written emotional disclosure: testing whether social disclosure matters. J Soc Clin Psychol. 2007; 26:362-384.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark A Lumley PhD.

Additional information

Implications

Researchers: There are a number of methodological issues to consider in conducting emotional disclosure research with chronic pain populations, including method, location, and selection of participants.

Practitioners: Many patients with chronic pain have unresolved stressful experiences contributing to their pain, and emotional disclosure techniques can supplement other interventions for such patients.

Policymakers: Interventions such as emotional disclosure that encourage patients to process negative emotional experiences should be explored as one facet of multicomponent interventions.

Preparation of this article was supported, in part, by the National Institute of Health grants AR057808 and AR057047.

About this article

Cite this article

Lumley, M.A., Sklar, E.R. & Carty, J.N. Emotional disclosure interventions for chronic pain: from the laboratory to the clinic. Behav. Med. Pract. Policy Res. 2, 73–81 (2012). https://doi.org/10.1007/s13142-011-0085-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13142-011-0085-4

KEYWORDS

Navigation